Since treatment with DHT or ASC-J9 did not induce ovarian cancer cell death (Fig. 4c), our results indicate that androgen induced Nanog gene promoter activity in ovarian cancer cells through the AR signaling axis. The gene discussed is AR; the disease is ovarian carcinoma.